Mometasone
Mometasone is a corticosteroid available in nasal, inhaled, topical, and sinus implant forms, used to treat seasonal allergic rhinitis, chronic rhinosinusitis with nasal polyps, asthma, and inflammatory skin conditions.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 37 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Mometasone: Patient Information Guide
A plain-language walkthrough of Mometasone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Mometasone is a corticosteroid available in multiple forms, each approved for specific uses — so the form and brand matter.
- Nasal spray (mometasone furoate monohydrate / mometasone furoate nasal spray, Nasonex): Prevents nasal symptoms of seasonal allergic rhinitis in adults and children 12 and older; treats chronic rhinosinusitis with nasal polyps in adults 18 and older
- OTC nasal spray (Nasonex OTC and store brands): Temporarily relieves hay fever and upper respiratory allergy symptoms including congestion, runny nose, sneezing, and itchy nose
- Asmanex Twisthaler (inhaled dry powder): Long-term maintenance treatment of asthma in patients 4 years and older; not for acute bronchospasm
- Asmanex HFA (inhaled aerosol): Long-term maintenance treatment of asthma in patients 5 years and older; not for acute bronchospasm
- Topical cream and ointment (0.1%): Relieves inflammation and itching from corticosteroid-responsive skin conditions in patients 2 years and older
- Topical lotion/solution (0.1%): Relieves inflammation and itching from corticosteroid-responsive skin conditions in patients 12 years and older
- Sinuva sinus implant: Treats chronic rhinosinusitis with nasal polyps in adults 18 and older who have already had ethmoid sinus surgery; placed by an ENT physician
⚙️How it works▾
Mometasone is a potent corticosteroid that binds to glucocorticoid receptors inside cells — the same receptors your body's own stress hormone (cortisol) uses. This triggers a broad anti-inflammatory effect: it quiets immune cells like mast cells and eosinophils and reduces the release of inflammatory chemicals like histamine and leukotrienes that cause swelling, itching, and airway narrowing. When applied to the right tissue — nasal passages, lungs, or skin — this calming effect directly targets the source of symptoms.
Because it works by changing how cells behave rather than by blocking a single chemical instantly, mometasone takes time to reach its full effect. With inhaled use for asthma, maximum benefit may not arrive for one to two weeks or longer after starting treatment.
💊How it's taken▾
The right dose and timing depend entirely on which form of mometasone you are using — so always follow your prescriber's directions for your specific product.
- Nasal spray: Typically 2 sprays in each nostril once daily for allergic rhinitis (adults and children 12+); twice daily for nasal polyps in adults. The OTC children's version (ages 2–11) uses 1 spray per nostril once daily. Prime the pump before first use and reprime if unused for more than a week.
- Asmanex Twisthaler / Asmanex HFA (inhaled): Inhaled twice daily by mouth. After each use, rinse your mouth with water and spit it out — do not swallow. This reduces the risk of a yeast infection in the mouth. Maximum benefit may take 1–2 weeks or longer.
- Topical cream or ointment: A thin film applied to affected skin once daily. Stop when the skin clears; if no improvement in 2 weeks, contact your doctor. Do not use on the face, groin, or underarms unless directed, and avoid airtight coverings over the treated area.
- Sinuva sinus implant: Inserted by an ENT doctor in an office setting; gradually releases medication for up to 90 days, then is removed.
🤒Side effects — in detail▾
The most common side effects vary by how mometasone is used, but across all forms the ones reported most often include:
- Headache
- Sore throat (pharyngitis) and upper respiratory infections
- Oral yeast infection (thrush) — most common with inhaled forms; rinsing your mouth after each dose greatly reduces this risk
- Sinusitis
- Nasal irritation or nosebleeds (nasal spray)
- Muscle or back pain (inhaled forms)
- Stomach upset or indigestion (inhaled forms)
- Skin irritation, burning, or thinning (topical forms)
More serious reactions to watch for include sudden severe breathing problems, signs of a serious allergic reaction (throat swelling, hives, anaphylaxis), eye pain or vision changes with long-term use, and in children, slower-than-expected growth — all of these warrant a call to your doctor promptly.
⚠️Warnings & precautions▾
- Not for emergency use: Inhaled mometasone (Asmanex) does not work fast enough to treat a sudden asthma attack. Always have a rescue inhaler (like albuterol) available. If an attack is not responding to rescue treatment, seek emergency care.
- Mouth and throat yeast infection: Inhaled corticosteroids can cause Candida (thrush) — white patches in the mouth or throat. Rinsing and spitting after every dose helps prevent this.
- Immune suppression: Corticosteroids can make infections like chickenpox or measles more dangerous. If you haven't had these illnesses or been vaccinated, take steps to avoid exposure. Use with extra caution if you have tuberculosis, a fungal infection, herpes of the eye, or other active infections.
- Adrenal suppression: If you are switching from oral steroids to inhaled or nasal mometasone, do not stop oral steroids suddenly. Your adrenal glands need months to recover, and during stress, surgery, or illness you may need extra corticosteroid support.
- Bone density: Long-term inhaled corticosteroid use can reduce bone mineral density. People with risk factors for osteoporosis should be monitored.
- Eye effects: Long-term use has been linked to glaucoma (increased eye pressure) and cataracts. Report any eye symptoms to your doctor.
- Children's growth: Nasal and inhaled corticosteroids may slow growth in children. A doctor should monitor height regularly and use the lowest effective dose.
- Paradoxical bronchospasm: Rarely, the inhaler can trigger immediate worsening of wheezing. Stop use immediately and use a rescue bronchodilator if this happens.
🔀What it interacts with▾
Mometasone has a relatively limited interaction profile, but one category matters significantly:
- Strong CYP3A4 inhibitors — including ketoconazole, ritonavir, cobicistat (and cobicistat-containing HIV medications), atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, and telithromycin — can block the enzyme that breaks down mometasone. This raises mometasone levels in the blood and increases the risk of systemic steroid side effects like adrenal suppression. Use together with caution and watch for steroid-related side effects.
- Short-acting bronchodilators and intranasal corticosteroids used alongside inhaled mometasone have not shown increased adverse effects in clinical trials, but always tell your prescriber about all medications you take.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergic to milk proteins? Asmanex Twisthaler is contraindicated — it contains milk proteins. Tell your doctor before using it.
- Active infections: Tell your doctor if you have tuberculosis, an untreated fungal, bacterial, viral, or parasitic infection, or herpes of the eye — mometasone can make these harder to fight.
- Switching from oral steroids: A slow, supervised taper is essential. Stopping oral steroids too quickly when starting mometasone can leave your adrenal glands unable to respond to stress.
- Pregnancy: Animal studies showed fetal effects at certain doses, though nasal use results in minimal systemic absorption. Discuss the benefits and risks with your doctor.
- Breastfeeding: Nasal use leads to very little systemic absorption; the infant is not expected to be exposed through breast milk. Still, discuss with your doctor.
- Children: Different minimum ages apply by product. Monitor growth regularly with nasal or inhaled forms. Topical cream and ointment: approved age 2+; lotion: approved age 12+. Nasal polyp use is not established under age 18.
- Liver disease: Mometasone levels may be higher in people with hepatic impairment; your doctor should be aware of this.
- Older adults: Clinical studies showed no notable difference in safety or effectiveness compared to younger adults, but standard steroid precautions still apply.
🚑If you take too much▾
There are no reports of acute overdose problems with mometasone nasal spray, and because very little is absorbed into the bloodstream through the nose, serious effects from an accidental extra dose are unlikely. That said, using more than directed over a long period can lead to signs of too much cortisol in the body — called hypercorticism — such as weight gain around the face and midsection, easy bruising, or fatigue. If you think you or someone else has used too much, contact your doctor or a poison control center.
📡Pharmacodynamics — effects in the body▾
When used as a nasal spray at recommended doses, mometasone showed no statistically significant effect on the body's cortisol levels in multiple studies — meaning it works locally in the nasal passages without meaningfully suppressing the adrenal glands at normal doses. With inhaled use (Asmanex), some measurable reduction in 24-hour cortisol levels has been observed at higher doses, consistent with the known systemic effects of inhaled corticosteroids. This is why staying at the lowest effective dose matters, especially for long-term use.
🔬Pharmacokinetics — how your body processes it▾
Mometasone is designed to act locally with minimal absorption into the bloodstream. With nasal use, systemic bioavailability is very low. With oral inhalation (Asmanex HFA), the drug is absorbed with peak blood levels reached within about 30 minutes to 2 hours. Oral bioavailability is negligible — meaning that any swallowed drug is not meaningfully absorbed. The main pathway for breaking down mometasone in the body is through a liver enzyme called CYP3A4, which is why drugs that block that enzyme can raise mometasone blood levels significantly.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F) . Avoid excessive heat.
📄 Written from Mometasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Mometasone — the kind of thing our pharmacy team would talk through with you at the counter.
Can I use my mometasone nasal spray or inhaler when I'm having an allergy attack or asthma flare right now? ▾
I've been using the Asmanex inhaler for a week and I still feel the same. Is it working? ▾
My doctor just prescribed mometasone cream for my skin. Are there any spots I should avoid putting it on? ▾
I've heard that mouth infections can happen with inhalers. How do I avoid that? ▾
Is it safe to use this if I'm pregnant or breastfeeding? ▾
I was on oral prednisone for a long time and my doctor is switching me to an inhaled mometasone. Do I just stop the prednisone? ▾
Is Mometasone available over the counter? ▾
When was Mometasone first available? ▾
Who makes Mometasone? ▾
💬 Answers drafted from Mometasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Mometasone comes
Mometasone is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
Nasal spray
Inhaler
Topical solution
Insert or device
📊 Mometasone across the U.S. market
How Mometasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (38) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Mometasone is used
A general measure of how commonly Mometasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Mometasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Mometasone prescribed? Of the 1,596 medications we measure, Mometasone ranks #225 by Medicaid prescriptions — more than 86% of them.
Utilization by Mometasone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
mometasone furoate 1 MG/ML Topical Cream Most dispensed
Summed across the 4 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311753
mometasone furoate 0.001 MG/MG Topical Ointment
Summed across the 4 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 151029
mometasone furoate 1 MG/ML Topical Lotion
Summed across the 4 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 151030
mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray
Summed across the 8 of 32 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1797865
Other Mometasone products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 8 of 96 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Mometasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 28 of 200 listed Mometasone NDCs with Medicaid activity.
🔍 Compare Mometasone products
A representative set of FDA-listed product records for Mometasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 50 mcg | — | Kindeva Drug Delivery Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mcg | — | Kindeva Drug Delivery Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 200 mcg | — | Kindeva Drug Delivery Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 110 mcg | — | MSD International GmbH (Singapore Branch) | DRUG FOR FURTHER PROCESSING | View NDC → |
| 220 mcg | — | MSD International GmbH (Singapore Branch) | DRUG FOR FURTHER PROCESSING | View NDC → |
| 50 mcg | Respiratory (inhalation) | Organon LLC × 4 listings | NDA | View NDC → |
| 100 mcg | Respiratory (inhalation) | Organon LLC × 4 listings | NDA | View NDC → |
| 110 mcg | Respiratory (inhalation) | Organon LLC × 3 listings | NDA | View NDC → |
| 200 mcg | Respiratory (inhalation) | Organon LLC × 4 listings | NDA | View NDC → |
| 220 mcg | Respiratory (inhalation) | Organon LLC × 3 listings | NDA | View NDC → |
| 1 kg/kg | — | Sterling Spa | BULK INGREDIENT | View NDC → |
| 💊Insert or device | ||||
| 1350 mcg | Intrasinal | Intersect ENT, Inc. × 2 listings | NDA | View NDC → |
| 1350 mcg | — | Synergy Health, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Nasal spray | ||||
| 50 mcg | Nasal | Amazon.com Services LLC × 2 listings | NDA | View NDC → |
| 50 mcg | Nasal | Amneal Pharmaceuticals LLC × 3 listings | ANDA | View NDC → |
| 50 mcg | Nasal | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 50 mcg | Nasal | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 50 mcg | Nasal | Aurobindo Pharma Limited | ANDA | View NDC → |
| 50 mcg | Nasal | Aurohealth LLC | ANDA | View NDC → |
| 50 mcg | Nasal | Cardinal Health 110, LLC. dba Leader × 2 listings | NDA | View NDC → |
| 50 mcg | Nasal | Cvs Woonsocket Prescription Center, Incorporated × 2 listings | NDA | View NDC → |
| 50 mcg | Nasal | Golden State Medical Supply, Inc. × 3 listings | ANDA | View NDC → |
| 50 mcg | Nasal | HyVee Inc | NDA | View NDC → |
| 50 mcg | Nasal | L. Perrigo Company × 6 listings | NDA | View NDC → |
| 50 mcg | Nasal | Rite Aid Corporation | NDA | View NDC → |
| 50 mcg | Nasal | Rugby Laboratories × 2 listings | NDA | View NDC → |
| 50 mcg | Nasal | Target Corporation | NDA | View NDC → |
| 50 mcg | Nasal | Topco Associates LLC × 3 listings | NDA | View NDC → |
| 50 mcg | Nasal | Walgreen Company × 2 listings | NDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 1 mg/g | Topical | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Bryant Ranch Prepack × 19 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 5 listings | ANDA | View NDC → |
| 1 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 1 mg/mL | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA × 4 listings | ANDA | View NDC → |
| 1 mg/mL | Topical | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Northstar Rx Llc × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 3 listings | ANDA | Find on DailyMed ↗ |
| 1 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 5 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Perrigo New York Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Preferred Pharmaceuticals Inc. × 8 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Proficient Rx LP × 4 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Remedyrepack Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | RPK Pharmaceuticals, Inc. × 4 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Sportpharm LLC | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Topical | Torrent Pharmaceuticals Limited × 3 listings | ANDA | View NDC → |
| 💊Topical solution | ||||
| 1 mg/mL | Topical | Bryant Ranch Prepack × 7 listings | ANDA | View NDC → |
| 1 mg/mL | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg/mL | Topical | Padagis Israel Pharmaceuticals Ltd × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1 mg/mL | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Aarti Pharmalabs Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | AX Pharmaceutical Corp | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 25 kg/25 kg | — | Cipla Ltd. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Coral Drugs Private Limited × 3 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Curia Spain S.A.U. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Fagron Inc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Farmabios S.p.A. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Henan Lihua Pharmaceutical Co Ltd | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Hovione FarmaCiencia SA × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Industriale Chimica s.r.l. × 4 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Newchem Spa | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 100 kg/100 kg | — | Sicor de Mexico S.A. de C.V × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Sterling S.p.A. × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Sterling Spa | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Suresource Pharma LLC | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Symbiotec Pharmalab Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Symbiotica Speciality Ingredients Sdn.bhd | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Vamsi Labs Limited. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Wavelength Enterprises LTD × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Willow Birch Pharma, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | zhejiang xianju pharmaceutical co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 187 of 187 products — FDA National Drug Code Directory. See every product, package size and price: browse all 187 Mometasone NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Mometasone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Mometasone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Mometasone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 108118 7 dose forms · 14 strengths
-
Dose form (SCDF) Drug Implant RxCUI 1148518In current FDA listings -
Dose form (SCDF) Dry Powder Inhaler RxCUI 746792No current FDA listingClinical drug / strength (SCD) 14 ACTUAT mometasone furoate 0.22 MG/ACTUATRxCUI 74681030 ACTUAT mometasone furoate 0.11 MG/ACTUATRxCUI 79028330 ACTUAT mometasone furoate 0.22 MG/ACTUATRxCUI 74681260 ACTUAT mometasone furoate 0.22 MG/ACTUATRxCUI 746814120 ACTUAT mometasone furoate 0.22 MG/ACTUATRxCUI 746803 -
Dose form (SCDF) Metered Dose Inhaler RxCUI 1536141In current FDA listingsClinical drug / strength (SCD) 120 ACTUAT mometasone furoate 0.05 MG/ACTUATRxCUI 2196790120 ACTUAT mometasone furoate 0.1 MG/ACTUATRxCUI 1536142120 ACTUAT mometasone furoate 0.2 MG/ACTUATRxCUI 1536147 -
Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797864In current FDA listingsClinical drug / strength (SCD) furoate 0.05 MG/ACTUATRxCUI 1797865 -
Dose form (SCDF) Topical Cream RxCUI 619083In current FDA listingsClinical drug / strength (SCD) furoate 1 MG/MLRxCUI 311753 -
Dose form (SCDF) Topical Lotion RxCUI 619119In current FDA listingsClinical drug / strength (SCD) furoate 1 MG/MLRxCUI 151030 -
Dose form (SCDF) Topical Ointment RxCUI 619042In current FDA listingsClinical drug / strength (SCD) furoate 0.001 MG/MGRxCUI 151029
Look up RxCUI 108118 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Mometasone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Mometasone belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 37 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. RPK Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.